HomeVKTX • NASDAQ
add
Viking Therapeutics Inc
Nakaraang pagsara
$40.60
Sakop ng araw
$38.35 - $40.16
Sakop ng taon
$20.28 - $99.41
Market cap
4.38B USD
Average na Volume
3.27M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | — | — |
Gastos sa pagpapatakbo | 36.56M | 34.08% |
Net na kita | -24.94M | -10.68% |
Net profit margin | — | — |
Kita sa bawat share | -0.22 | 4.35% |
EBITDA | — | — |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 930.44M | 147.30% |
Kabuuang asset | 937.89M | 145.10% |
Kabuuang sagutin | 26.44M | 83.32% |
Kabuuang equity | 911.45M | — |
Natitirang share | 111.44M | — |
Presyo para makapag-book | 4.96 | — |
Return on assets | -9.70% | — |
Return on capital | -9.96% | — |
Cash Flow
Net change in cash
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -24.94M | -10.68% |
Cash mula sa mga operasyon | -21.96M | -11.72% |
Cash mula sa pag-invest | 25.90M | 306.65% |
Cash mula sa financing | 2.52M | 3,508.11% |
Net change in cash | 6.43M | 119.89% |
Malayang cash flow | -16.07M | -43.86% |
Tungkol
CEO
Itinatag
2012
Website
Mga Empleyado
31
